Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications

The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranganathan, Ramya, Madanmohan, Shruthilaya, Kesavan, Akila, Baskar, Ganga, Krishnamoorthy, Yoganathan Ramia, Santosham, Roy, Ponraju, D, Rayala, Suresh Kumar, Venkatraman, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292417/
https://www.ncbi.nlm.nih.gov/pubmed/22403487
http://dx.doi.org/10.2147/IJN.S25182
_version_ 1782225269911715840
author Ranganathan, Ramya
Madanmohan, Shruthilaya
Kesavan, Akila
Baskar, Ganga
Krishnamoorthy, Yoganathan Ramia
Santosham, Roy
Ponraju, D
Rayala, Suresh Kumar
Venkatraman, Ganesh
author_facet Ranganathan, Ramya
Madanmohan, Shruthilaya
Kesavan, Akila
Baskar, Ganga
Krishnamoorthy, Yoganathan Ramia
Santosham, Roy
Ponraju, D
Rayala, Suresh Kumar
Venkatraman, Ganesh
author_sort Ranganathan, Ramya
collection PubMed
description The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems.
format Online
Article
Text
id pubmed-3292417
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32924172012-03-08 Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications Ranganathan, Ramya Madanmohan, Shruthilaya Kesavan, Akila Baskar, Ganga Krishnamoorthy, Yoganathan Ramia Santosham, Roy Ponraju, D Rayala, Suresh Kumar Venkatraman, Ganesh Int J Nanomedicine Review The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the serious side effects caused by anticancer agents as a result of their cytotoxic actions on normal cells. This nonspecific action of chemotherapy has awakened a need for formulations capable of definitive targeting with enhanced tumor-killing. Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important area of nanomedicine. Currently several nanomaterial-based drug-delivery systems are in vogue and several others are in various stages of development. Tumor-targeted drug-delivery systems are envisioned as magic bullets for cancer therapy and several groups are working globally for development of robust systems. Dove Medical Press 2012 2012-02-23 /pmc/articles/PMC3292417/ /pubmed/22403487 http://dx.doi.org/10.2147/IJN.S25182 Text en © 2012 Ranganathan et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Ranganathan, Ramya
Madanmohan, Shruthilaya
Kesavan, Akila
Baskar, Ganga
Krishnamoorthy, Yoganathan Ramia
Santosham, Roy
Ponraju, D
Rayala, Suresh Kumar
Venkatraman, Ganesh
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_full Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_fullStr Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_full_unstemmed Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_short Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
title_sort nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292417/
https://www.ncbi.nlm.nih.gov/pubmed/22403487
http://dx.doi.org/10.2147/IJN.S25182
work_keys_str_mv AT ranganathanramya nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT madanmohanshruthilaya nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT kesavanakila nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT baskarganga nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT krishnamoorthyyoganathanramia nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT santoshamroy nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT ponrajud nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT rayalasureshkumar nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications
AT venkatramanganesh nanomedicinetowardsdevelopmentofpatientfriendlydrugdeliverysystemsforoncologicalapplications

Ejemplares similares